Trial intelligence / Profile preview

Benzoyl peroxide for reducing Cutibacterium acnes on shoulder skin

NL-OMON48905Recruiting

Sponsor
Sint Maartenskliniek
Start
Jan 2019
Modality
Small Molecules
Countries
1
01

Overview

Randomised, double-blind trial in Cutibacterium acnes colonization comparing Benzoyl peroxide with Placebo (2 arms). Primary endpoint: Presence of Cutibacterium acnes on the skin of the shoulder. Started Jan 2019; status: recruiting.

02

Drugs

benzoyl peroxide
03

Conditions

Cutibacterium acnes colonization

Beyond the preview

Go deeper on NL-OMON48905.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON48905.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call